Olfr738, encoded by the Or11g1 gene in house mice, is part of the olfactory receptor family, a group of G-protein-coupled receptors (GPCRs) responsible for detecting odorants and initiating neuronal responses that lead to the perception of smell. These receptors have a characteristic 7-transmembrane domain structure and function through the recognition and transduction of odorant signals via G protein activation. This activation triggers a cascade of intracellular signaling events, primarily involving the production of secondary messengers like cyclic AMP (cAMP). The inhibition of Olfr738, and olfactory receptors in general, involves understanding their complex signaling pathways and the broader neurochemical environment in which they operate. As GPCRs, these receptors are influenced by the levels and interactions of various neurotransmitters and their respective receptors. Indirect inhibition can occur through several mechanisms. One primary route is the modulation of cAMP levels, a key secondary messenger in GPCR signaling. Compounds that influence the production or degradation of cAMP can, therefore, have an indirect impact on the signaling of olfactory receptors. This is because the activation and function of these receptors often depend on the cellular concentration of cAMP, which in turn regulates various downstream processes.
Another indirect method of inhibition involves the modulation of neurotransmitter systems. This includes the use of antagonists for adrenergic, dopaminergic, or serotonergic receptors. By influencing these neurotransmitter systems, it is possible to indirectly affect the functioning of olfactory receptors. Changes in neurotransmitter levels or receptor dynamics can alter the overall signaling environment in which GPCRs operate, potentially modifying their activity. In summary, the inhibition of Olfr738, a GPCR in the olfactory system, can potentially be achieved indirectly by targeting the key components of its signaling pathways. This includes manipulating cAMP levels or modulating various neurotransmitter systems. Understanding these pathways and their interconnections is crucial for exploring how to influence the function of olfactory receptors like Olfr738 indirectly.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a beta-adrenergic antagonist that decreases cAMP levels, a secondary messenger in GPCR signaling. Reduced cAMP may indirectly affect Olfr738 signaling, as cAMP is crucial in olfactory receptor transduction processes. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $122.00 $235.00 $520.00 $979.00 $1500.00 | 2 | |
Carvedilol, a beta-blocker with alpha-1 blocking activity, can lower cAMP levels by inhibiting adrenergic receptors. This could indirectly influence Olfr738 signaling pathways due to the role of cAMP in GPCR-mediated olfactory transduction. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $50.00 $168.00 $520.00 | 2 | |
As an alpha-2 adrenergic antagonist, Yohimbine increases neurotransmitter release, possibly affecting GPCR signaling, including Olfr738 pathways, by modifying the neurotransmitter balance and receptor interactions. | ||||||
Ketanserin | 74050-98-9 | sc-279249 | 1 g | $700.00 | ||
Ketanserin, a 5-HT2A serotonin receptor antagonist, alters serotonin signaling, potentially affecting Olfr738 indirectly due to the role of serotonin in modulating GPCR pathways. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A | 50 mg 500 mg | $68.00 $357.00 | 11 | |
Clozapine, an atypical antipsychotic, affects multiple neurotransmitter systems. This broad action could indirectly impact Olfr738 signaling by altering neurotransmitter levels and receptor dynamics. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
As a dopamine antagonist, Haloperidol influences dopaminergic pathways, which could indirectly affect Olfr738 signaling by modulating dopaminergic activity and receptor interactions. | ||||||
Risperidone | 106266-06-2 | sc-204881 sc-204881A sc-204881B sc-204881C | 10 mg 50 mg 1 g 5 g | $171.00 $705.00 $1000.00 $2000.00 | 1 | |
Risperidone, acting on both dopamine and serotonin receptors, could indirectly impact Olfr738 signaling by affecting neurotransmitter systems and GPCR-mediated pathways. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $80.00 $326.00 | 1 | |
Ondansetron, a 5-HT3 receptor antagonist, could indirectly affect Olfr738 by altering serotonin signaling, which is integral to GPCR-mediated pathways in olfactory transduction. | ||||||
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $77.00 $408.00 | 1 | |
Atenolol, a selective beta1-adrenergic antagonist, could influence Olfr738 indirectly by modulating adrenergic activity and cAMP levels, crucial in GPCR signaling. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $105.00 $238.00 | 3 | |
By selectively blocking beta1-adrenergic receptors, Metoprolol could indirectly affect Olfr738 signaling pathways through alterations in cAMP levels and adrenergic signaling. | ||||||